Stay updated on Eteplirsen Safety in Early Duchenne Clinical Trial
Sign up to get notified when there's something new on the Eteplirsen Safety in Early Duchenne Clinical Trial page.

Latest updates to the Eteplirsen Safety in Early Duchenne Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check46 days agoChange Detected- Revision: v3.4.3 updated from v3.4.2.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page now displays Revision: v3.4.2 and the previous funding-status notice (Revision: v3.4.1) has been removed.SummaryDifference0.4%

- Check82 days agoChange DetectedAdded an administrative notice about government funding and site status, and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check89 days agoChange DetectedAdded a Show glossary option and updated labels to Last Update Submitted that Met QC Criteria and Revision: v3.4.0. Removed the previous labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

Stay in the know with updates to Eteplirsen Safety in Early Duchenne Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eteplirsen Safety in Early Duchenne Clinical Trial page.